Medical Device Reading List, November 13 2016

Enjoy the latest collection of news and analysis from the world of medical devices, curated by Chris Ware (@ware_am_i).

The last week was full of quarterly earnings updates, including $SYK, $ZBH, $EW, $BSX, and $BAX.

St. Jude Medical (STJ) Announces FDA Approval, U.S. Launch of Medical Device to Reduce Risk of Recurrent Ischemic Stroke in Patients with PFO
Street Insider ($STJ)​

St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical Trials and Highlights Its Latest Cardiovascular Portfolio at the 2016 TCT Conference
Press Release ($STJ)

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation
Sarah Pringle, The Street ($BSX)

St. Jude Medical (STJ) Shareholders Approve Abbott (ABT) Merger
Street Insider ($STJ, $ABT)

Stryker (SYK) Down despite Q3 Earnings and Revenue Beat
Zacks ($SKY)

Zimmer Biomet Holdings (ZBH) Announces Acquisition of RespondWell
Street Insider ($ZBH)

Edwards Lifesciences (EW) Reports In-Line Q3 EPS
Street Insider ($EW)

Boston Scientific (BSX) Reports In-Line Q3 EPS; Modestly Lifts Outlook
Street Insider ($EW)

Baxter International (BAX) Beats Q3 Earnings & Sales
Yahoo! Finance ($BAX)